Detalhe da pesquisa
1.
International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients.
Medicina (Kaunas);
59(1)2023 Jan 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36676807
2.
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis.
Scand J Gastroenterol;
57(4): 424-431, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34932423
3.
Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
J Med Internet Res;
23(12): e30291, 2021 12 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34904950
4.
eHealth: Disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis.
Scand J Gastroenterol;
55(11): 1291-1300, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33045169
5.
Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey.
J Clin Med;
13(9)2024 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38731039
6.
Management and treatment optimization of patients with mild to moderate ulcerative colitis.
Expert Rev Clin Immunol;
20(3): 277-290, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38059454
7.
Assessment of the effectiveness of Budesonide MMX® for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study.
Prz Gastroenterol;
18(2): 154-160, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37538282
8.
Efficacy of oral prolonged-release mesalazine in moderately active ulcerative colitis.
JGH Open;
7(7): 516-519, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37496812
9.
Fertility and Assisted Reproductive Technologies Outcomes of Women with Non-surgically Managed Inflammatory Bowel Diseases: A Systematic Review.
J Crohns Colitis;
17(4): 614-632, 2023 Apr 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36322700
10.
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey.
Microorganisms;
11(11)2023 Nov 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38004817
11.
Non-invasive monitoring and treat-to-target approach are cost-effective in patients with mild-moderate ulcerative colitis.
Aliment Pharmacol Ther;
57(5): 486-495, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36377366
12.
Inflammatory bowel disease meets fertility: A physician and patient survey.
Dig Liver Dis;
55(7): 888-898, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36697343
13.
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis.
J Clin Med;
12(3)2023 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36769791
14.
Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey.
BMC Gastroenterol;
12: 108, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22894661
15.
Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review.
United European Gastroenterol J;
10(8): 854-867, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36029157
16.
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis.
BMJ Open Gastroenterol;
9(1)2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35165124
17.
Efficacy and safety of oral Pentasa (prolonged-release mesalazine) in mild-to-moderate ulcerative colitis: a systematic review and meta-analysis.
Curr Med Res Opin;
37(11): 1891-1900, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34404286
18.
'Treat to Target' in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy.
Curr Drug Targets;
22(1): 117-125, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32718289
19.
Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis.
J Clin Med;
9(9)2020 Sep 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32911840
20.
The use of 5-aminosalicylates in Crohn's disease: a retrospective study using the UK Clinical Practice Research Datalink.
Ann Gastroenterol;
33(5): 500-507, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32879597